YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQWG6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,908
Award facts
- Contract value 100% obligated
- $8,908.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,908.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on December 16, 2025, with an ultimate completion date of January 8, 2026. No set-aside designation was applied to this contract, indicating DMS Pharmaceutical Group competed in an unrestricted procurement environment. This delivery order represents a discrete purchase under DMS Pharmaceutical Group's broader relationship with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for the Department of Defense. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue multiple delivery orders for a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a regional prime vendor contractor reflects its demonstrated capability to supply specialized pharmaceutical products, including vaccines and biologics, to federal military medical systems.
Quick answers
Who was awarded contract SPE2DR26FQWG6?
SPE2DR26FQWG6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FQWG6 worth?
The government has obligated $8,908 on SPE2DR26FQWG6.
Is contract SPE2DR26FQWG6 an order under another contract?
Yes. SPE2DR26FQWG6 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWG6 competed?
The extent of competition for SPE2DR26FQWG6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award